Canada Pension Plan Investment Board 13F: Adds $65M to ABT Stake
The Canada Pension Plan Investment Board increases its position in Abbott Laboratories significantly in its latest filing.
Reviewed by automated data checks against the source filing. How we make and check alerts
Canada Pension Plan Investment Board added 691,435 shares to its stake in Abbott Laboratories ($ABT), a 36.44% increase, according to a 13F filing with the SEC dated May 15, 2026. It reported 2,588,711 shares worth $243.65 million at the end of the quarter.
Since the filing, $ABT is up 3.5% after 1 week, up 5.0% after 1 month and up 25.8% to date (from the $83.36 close on May 15, 2026).
Find the original: Canada Pension Plan Investment Board 13F filings on SEC EDGAR
ABT
Abbott Laboratories
Key Points
- The Canada Pension Plan Investment Board boosted its holdings in Abbott Laboratories by 691,435 shares, raising its total to 2,588,711 shares valued at approximately $243.6 million as of May 15, 2026.
- Abbott's stock is currently trading around $94.12, showing a 36.4% increase in the fund's position, which reflects a strong belief in the company's future potential.
- Analysts maintain a bullish outlook on Abbott, with a consensus strong buy recommendation and a mean price target of $120.72.
Get $ABT trade alerts by text
We text you when insiders, Congress or big funds trade $ABT. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Abbott Laboratories alert may contain errors. Disclosures
Canada Pension Plan Investment Board Boosts Stake
The Canada Pension Plan Investment Board has boosted its stake in Abbott Laboratories (NYSE: ABT) by 691,435 shares, increasing its total holdings to 2,588,711 shares valued at about $243.6 million, according to its latest Form 13F filing reflecting the position as of May 15, 2026.
Canada Pension Plan Investment Board vs. the S&P 500
Hypothetical returns from Canada Pension Plan Investment Board's disclosed trades, not real profit or advice. How we model this.
What Changed in the Position
The Canada Pension Plan Investment Board's holdings grew by a 36.4% increase from its previous count of 1,897,276 shares. This significant addition highlights the fund's confidence in Abbott's performance.
Institutional Activity in Abbott
While no other funds reported changes in their positions for Abbott Laboratories, the Canada Pension Plan Investment Board's increase stands out in the current environment, suggesting a strategic move amid fluctuating market conditions.
How Abbott Laboratories Stock Has Traded
Abbott's stock is trading at approximately $94.12. This price is below its 52-week high of $132.03 and significantly above its low of $81.97, indicating a recovery phase. The stock's performance is noteworthy as it has seen considerable activity from institutional investors, which may signal confidence in its future growth.
Analysts Set New Price Targets
On October 16, 2026, TD Cowen reiterated its Buy rating on Abbott with a price target of $135. Earlier, on October 7, Barclays initiated coverage with an Overweight rating and a target of $120. Rothschild & Co upgraded its rating to Buy with a target of $127 on October 2. The consensus recommendation remains a strong buy, with a mean price target of $120.72 based on 26 analyst opinions.
What Abbott Laboratories Does
Abbott Laboratories is a healthcare company based in Abbott Park, Illinois. It develops and manufactures a wide range of health care products, including medical devices, diagnostics, and nutritional products. The recent increase in investment from the Canada Pension Plan Investment Board reflects ongoing interest in Abbott's innovative product pipeline.
What's Ahead for Abbott Laboratories
Investors will be watching for Abbott's next earnings report, scheduled for October 21, 2026, which will provide further insights into the company's financial health. Remember, the 13F filing reflects past positions and may not represent the current investment strategy of the Canada Pension Plan Investment Board.
Related Filing Alerts
Source: Canada Pension Plan Investment Board's 13F filing on $ABT (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Canada Pension Plan Investment Board 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts